Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 175 JPY -2.2% Market Closed
Market Cap: 33.4B JPY

Daito Pharmaceutical Co Ltd's latest stock split occurred on Aug 30, 2023

The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.

Before the split, Daito Pharmaceutical Co Ltd traded at 2260 per share. Afterward, the share price was about 2272.

The adjusted shares began trading on Aug 30, 2023. This was Daito Pharmaceutical Co Ltd's 2nd stock split, following the previous one in Mar 27, 2015.

Last Splits:
Aug 30, 2023
1-for-1
Mar 27, 2015
1-for-1
Pre-Split Price
2 260 2 260
Post-Split Price
2 272
Before
After
Last Splits:
Aug 30, 2023
1-for-1
Mar 27, 2015
1-for-1

Daito Pharmaceutical Co Ltd
Stock Splits History

Daito Pharmaceutical Co Ltd Stock Splits Timeline
Aug 30, 2023
Aug 30, 2023
Split 1-for-1
/1
Pre-Split Price
2 260 2 260
Post-Split Price
2 272
Before
After
Mar 27, 2015
Mar 27, 2015
Split 1-for-1
/1
Pre-Split Price
2 158.5428 2 363.6366
Post-Split Price
2 134.2175
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 1, 2025
I
Icon Energy Corp
NASDAQ:ICON
1-for-40
/40
0.0478 1.912 USD 1.79 1.79 USD
Apr 1, 2025
V
Vortex Energy Corp
CNSX:VRTX
1-for-10
/10
0.075 0.075 CAD 0.11 0.11 CAD
Apr 1, 2025
R
Resource Centrix Holdings Inc
CNSX:RECE
10-for-1
x10
2.4 0.24 CAD 0.24 0.24 CAD
Apr 1, 2025
V
Vortex Energy Corp
OTC:VTECF
1-for-10
/10
0.05 0.5 USD 0.0378 0.0378 USD
Mar 31, 2025
Utime Ltd
NASDAQ:WTO
1-for-10
/10
0.151 1.51 USD 1.58 1.58 USD
Load More

Daito Pharmaceutical Co Ltd
Glance View

Market Cap
33.3B JPY
Industry
Pharmaceuticals

Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.

Intrinsic Value
3 136.71 JPY
Undervaluation 31%
Intrinsic Value
Price
What is Intrinsic Value?
Back to Top
ALPHA SPREAD
Follow us
Join more than 243,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.